Active Ingredient Pegvisomant

Active Ingredient Details

What is the usage for Pegvisomant?

Pegvisomant is used to treat a certain condition called acromegaly. Acromegaly occurs when the body makes too much growth hormone and other natural substances such as insulin-like growth factor-I (IGF-I). Pegvisomant is usually used if you have not responded to other treatments (such as surgery, radiation, other medications). Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Pegvisomant works by blocking the action of growth hormone and by reducing the amount of IGF-I to normal levels.

How many products in the NDC database contain Pegvisomant?

The NDC database has 6 products with the active ingredient Pegvisomant. The following table lists all the products that have this active ingredient.

NDC Products with Pegvisomant

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
59267-5201Proprietary Name: PegvisomantInjection, Powder, Lyophilized, For SolutionPfizer Manufacturing Belgium NvACTIVE
59267-5376Proprietary Name: PegvisomantInjection, Powder, Lyophilized, For SolutionPfizer Manufacturing Belgium NvACTIVE
59267-9201Proprietary Name: PegvisomantInjection, Powder, Lyophilized, For SolutionPfizer Manufacturing Belgium NvACTIVE
59267-9301Proprietary Name: PegvisomantInjection, Powder, Lyophilized, For SolutionPfizer Manufacturing Belgium NvACTIVE
59267-9401Proprietary Name: PegvisomantInjection, Powder, Lyophilized, For SolutionPfizer Manufacturing Belgium NvACTIVE
64052-001Proprietary Name: PegvisomantPastePfizer Ireland Pharmaceuticals Unlimited CompanyACTIVE
<